FDA: Class I recall of Quidel Triage Cardiac Panels
Editor's Note The Food and Drug Administration (FDA), on July 17, identified the recall by Quidel Cardiovascular Inc of its Quidel Triage Cardiac Panels as Class I, the most serious. The recall was initiated because of reports of inaccurate tests showing lower than expected troponin levels in samples. A falsely…
FDA: Class I recall of Medtronic implantable cardioverter, cardiac resynchronization therapy defibrillators
Editor's Note The Food and Drug Administration (FDA), on July 18, identified the recall by Medtronic of its implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) as Class I, the most serious. Medtronic is recalling all ICDs and CRT-Ds, with glassed feedthroughs that were manufactured after 2017, as…
FDA: Class I recall of Draeger Medical’s Oxylog 3000 Plus Emergency and Transport Ventilators
Editor's Note The Food and Drug Administration (FDA), on July 13, identified the recall by Draeger Medical of its Oxylog 3000 Plus Emergency and Transport Ventilators as Class I, the most serious. The recall was initiated because of reports that the ventilator may not automatically switch back to using AC…
Free Daily News
- Cardiovascular disease trends raise alarms on primary care
- Study: Kidney transplants safe between donors, patients with HIV
- Study: Women more likely to die from postoperative complications after high-risk surgery
- Study: Same-day aquablation surgery safe for ASCs
- Outpatient, ASC clinicians share perspectives on upcoming NOPAIN Act implementation
- Study dispels orthopedic surgeon turnover myth
- Feds take action on Hurricane-wracked medical supply chain with wartime powers, drug compounding guidance
- Study: Wearable devices improve postoperative physical activity in lung cancer patients
- Digital twin technology aids cardiac surgery at Boston Children's Hospital
- Study: Staff shortages increase hospital infection rates